LUKE HATZIS

Medicare Part B coverage and reimbursement issues for biotechnology treatments and issues related to the Medicare Part D coverage, including issues found in H.R. 1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21

Medicare Part B coverage and reimbursement issues for biotechnology treatments and issues related to the Medicare Part D coverage, including issues found in H.R. 1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21

Issues regarding the Inflation Reduction Act (IRA) P.L. No: 117-169, drug pricing, and efforts to create a Neuroscience Center of Excellence at FDA. PBM Issues, including H.R./S._ Modernizing and Ensuring PBM Accountability Act and H.R./S._Lower Costs, More Transparency Act. Issues regarding effective solutions for improving clinical care in long-term care settings and other solutions aimed at improving the diagnosis and management of neuropsychiatric symptoms (NPS) in dementia. Orphan Drug Provisions included in HR.1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21. 340 program issues.

Update and reforms to Medicare payments for physicians and implementation of related provisions of the Medicare Access and CHIP Reauthorization Act (MACRA), including regulatory relief for physicians in the MACRA Quality Payment Program, evaluation and management (E/M) codes and related legislative issues related to payment for E/M codes, and qualified clinical data registries, including related provisions in H.R. 879 - Medicare Patient and Practice Stabilization Act of 2025, S. 891 - Bipartisan Health Care Act, and H.R. 1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21. Issues related to adequate network coverage for dermatologic care within Medicare Advantage plans and advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans. H.R.8163 - Provider Reimbursement Stability Act of 2026. Issues related to modifier 25 in the 2027 physician fee schedule.

Issues regarding the Inflation Reduction Act (IRA) P.L. No: 117-169, drug pricing, and efforts to create a Neuroscience Center of Excellence at FDA. Issues regarding effective solutions for improving clinical care in long-term care settings and other solutions aimed at improving the diagnosis and management of neuropsychiatric symptoms (NPS) in dementia. Orphan Drug Provisions included in HR.1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21. 340 program issues.

Legislative and regulatory issues related to emergency medicine, including provisions found in H.R. 1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21. Additionally, issues such as surprise medical billing; mental health including H.R.929 / S.266, Dr. Lorna Breen Health Care Provider Protection Reauthorization Act; Medicare payment including, H.R. 879 Medicare Patient and Practice Stabilization Act of 2025; workforce issues, drug shortages and rural emergency hospitals. Support of S. 891 the Bipartisan Health Care Act, S.1974 the Addressing Boarding and Crowding in the Emergency Department (ABC-ED) Act of 2025.

Medicare Part B coverage and reimbursement issues for biotechnology treatments and issues related to the Medicare Part D coverage, including issues found in H.R. 1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21

Adequacy of Medicare physician payments for physicians and implementation of the Medicare Access and CHIP Reauthorization Act, including related provisions in H.R. 879 Medicare Patient and Practice Stabilization Act of 2025, S. 891 the Bipartisan Health Care Act of 2025 and H.R. 1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21, and related to physician payment adjustment of 2.5%. Issues related to adequate network coverage for ophthalmology care within Medicare Advantage plans and advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans, Medicare reimbursement for telemedicine, and extending Medicare Telehealth Flexibilities. Use of step therapy in Medicare and health insurance coverage. Enhance Center for Medicare & Medicaid Innovation quality initiatives and patient access to Medicare Part B covered drugs, including monitor CMMI Medicare Part B drug-related demonstrations. H.R.8163 - Provider Reimbursement Stability Act of 2026.

Update and reforms to Medicare payments for physicians and implementation of related provisions of the Medicare Access and CHIP Reauthorization Act (MACRA), including regulatory relief for physicians in the MACRA Quality Payment Program, evaluation and management (E/M) codes and related legislative issues related to payment for E/M codes, and qualified clinical data registries, including related provisions in H.R. 879 - Medicare Patient and Practice Stabilization Act of 2025, S. 891 - Bipartisan Health Care Act, and H.R. 1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21. Issues related to adequate network coverage for dermatologic care within Medicare Advantage plans and advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans. H.R.8163 - Provider Reimbursement Stability Act of 2026.

Adequacy of Medicare physician payments for physicians and implementation of the Medicare Access and CHIP Reauthorization Act, including related provisions in H.R. 879 Medicare Patient and Practice Stabilization Act of 2025, S. 891 the Bipartisan Health Care Act of 2025 and H.R. 1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21, and related to physician payment adjustment of 2.5%. Issues related to adequate network coverage for ophthalmology care within Medicare Advantage plans and advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans, Medicare reimbursement for telemedicine, and extending Medicare Telehealth Flexibilities. Use of step therapy in Medicare and health insurance coverage. Enhance Center for Medicare & Medicaid Innovation quality initiatives and patient access to Medicare Part B covered drugs, including monitor CMMI Medicare Part B drug-related demonstrations. H.R.8163 - Provider Reimbursement Stability Act of 2026. Issues related to modifier 25 in the 2027 physician fee schedule.

Monitoring legislative and regulatory issues related to pharmacies. Medicaid prescription drug reimbursement. Pharmacy Benefit Manager provisions included in Public Law No. 119-75 - H.R. 7148 and H.R. 3164, the Main Street Pharmacy Access Act.

Monitoring legislative and regulatory issues related to pharmacies. Medicaid prescription drug reimbursement. Pharmacy Benefit Manager provisions included in Public Law No. 119-75 - H.R. 7148 and H.R. 3164, the Main Street Pharmacy Access Act.

Issues related to Tribal Health, Appropriations, and Health Care. H.R. 3620/S. 2098 - Southcentral Foundation Land Transfer Act of 2025.

Legislative and regulatory issues related to physical therapy. Workforce issues, including H.R. 4878/S. 2459_Enabling More of the Physical and Occupational Workforce to Engage in Rehabilitation Act. Pelvic Health, including H.R. 4074/S._Optimizing Postpartum Outcomes Act and issues related to PT in the military; H.R./S._Remove Duplicative Unnecessary Clerical Exchanges Act or REDUCE Act; H.R.5621 Physical Therapist Workforce and Patient Access Act.

Legislative and regulatory issues related to physical therapy. Workforce issues, including H.R. 4878/S. 2459_Enabling More of the Physical and Occupational Workforce to Engage in Rehabilitation Act. Pelvic Health, including H.R. 4074/S._Optimizing Postpartum Outcomes Act and issues related to PT in the military; H.R./S._Remove Duplicative Unnecessary Clerical Exchanges Act or REDUCE Act; H.R.5621 Physical Therapist Workforce and Patient Access Act.

Legislative and regulatory issues related to physical therapy. Workforce issues, including H.R. 4878/S. 2459_Enabling More of the Physical and Occupational Workforce to Engage in Rehabilitation Act. Pelvic Health, including H.R. 4074/S._Optimizing Postpartum Outcomes Act and issues related to PT in the military; H.R./S._Remove Duplicative Unnecessary Clerical Exchanges Act or REDUCE Act; H.R.5621 Physical Therapist Workforce and Patient Access Act.

Legislative and regulatory issues related to physical therapy. Workforce issues, including H.R. 4878/S. 2459_Enabling More of the Physical and Occupational Workforce to Engage in Rehabilitation Act. Pelvic Health, including H.R. 4074/S._Optimizing Postpartum Outcomes Act and issues related to PT in the military; H.R./S._Remove Duplicative Unnecessary Clerical Exchanges Act or REDUCE Act; H.R.5621 Physical Therapist Workforce and Patient Access Act.

Legislative and regulatory issues related to physical therapy. Workforce issues, including H.R. 4878/S. 2459_Enabling More of the Physical and Occupational Workforce to Engage in Rehabilitation Act. Pelvic Health, including H.R. 4074/S._Optimizing Postpartum Outcomes Act and issues related to PT in the military; H.R./S._Remove Duplicative Unnecessary Clerical Exchanges Act or REDUCE Act; H.R.5621 Physical Therapist Workforce and Patient Access Act.

Legislative and regulatory issues related to physical therapy. Workforce issues, including H.R. 4878/S. 2459_Enabling More of the Physical and Occupational Workforce to Engage in Rehabilitation Act. Pelvic Health, including H.R. 4074/S._Optimizing Postpartum Outcomes Act and issues related to PT in the military; H.R./S._Remove Duplicative Unnecessary Clerical Exchanges Act or REDUCE Act; H.R.5621 Physical Therapist Workforce and Patient Access Act.

Legislative and regulatory issues related to physical therapy. Workforce issues, including H.R. 4878/S. 2459_Enabling More of the Physical and Occupational Workforce to Engage in Rehabilitation Act. Pelvic Health, including H.R. 4074/S._Optimizing Postpartum Outcomes Act and issues related to PT in the military; H.R./S._Remove Duplicative Unnecessary Clerical Exchanges Act or REDUCE Act; H.R.5621 Physical Therapist Workforce and Patient Access Act.

Legislative and regulatory issues related to physical therapy. Workforce issues, including H.R. 4878/S. 2459_Enabling More of the Physical and Occupational Workforce to Engage in Rehabilitation Act. Pelvic Health, including H.R. 4074/S._Optimizing Postpartum Outcomes Act and issues related to PT in the military; H.R./S._Remove Duplicative Unnecessary Clerical Exchanges Act or REDUCE Act; H.R.5621 Physical Therapist Workforce and Patient Access Act.

Legislative and regulatory issues related to physical therapy. Workforce issues, including H.R. 4878/S. 2459_Enabling More of the Physical and Occupational Workforce to Engage in Rehabilitation Act. Pelvic Health, including H.R. 4074/S._Optimizing Postpartum Outcomes Act and issues related to PT in the military; H.R./S._Remove Duplicative Unnecessary Clerical Exchanges Act or REDUCE Act; H.R.5621 Physical Therapist Workforce and Patient Access Act.

Monitoring legislative and regulatory issues related to pharmacies. Medicaid prescription drug reimbursement. Pharmacy Benefit Manager provisions included in Public Law No. 119-75 - H.R. 7148 and H.R. 3164, the Main Street Pharmacy Access Act.

Monitoring legislative and regulatory issues related to pharmacies. Medicaid prescription drug reimbursement. Pharmacy Benefit Manager provisions included in Public Law No. 119-75 - H.R. 7148 and H.R. 3164, the Main Street Pharmacy Access Act.

Update and reforms to Medicare payments for physicians and implementation of related provisions of the Medicare Access and CHIP Reauthorization Act (MACRA), including regulatory relief for physicians in the MACRA Quality Payment Program, evaluation and management (E/M) codes and related legislative issues related to payment for E/M codes, and qualified clinical data registries, including related provisions in H.R. 879 - Medicare Patient and Practice Stabilization Act of 2025, S. 891 - Bipartisan Health Care Act, and H.R. 1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21. Issues related to adequate network coverage for dermatologic care within Medicare Advantage plans and advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans. H.R.8163 - Provider Reimbursement Stability Act of 2026. Issues related to modifier 25 in the 2027 physician fee schedule.

Update and reforms to Medicare payments for physicians and implementation of related provisions of the Medicare Access and CHIP Reauthorization Act (MACRA), including regulatory relief for physicians in the MACRA Quality Payment Program, evaluation and management (E/M) codes and related legislative issues related to payment for E/M codes, and qualified clinical data registries, including related provisions in H.R. 879 - Medicare Patient and Practice Stabilization Act of 2025, S. 891 - Bipartisan Health Care Act, and H.R. 1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21. Issues related to adequate network coverage for dermatologic care within Medicare Advantage plans and advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans. H.R.8163 - Provider Reimbursement Stability Act of 2026.

Update and reforms to Medicare payments for physicians and implementation of related provisions of the Medicare Access and CHIP Reauthorization Act (MACRA), including regulatory relief for physicians in the MACRA Quality Payment Program, evaluation and management (E/M) codes and related legislative issues related to payment for E/M codes, and qualified clinical data registries, including related provisions in H.R. 879 - Medicare Patient and Practice Stabilization Act of 2025, S. 891 - Bipartisan Health Care Act, and H.R. 1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21. Issues related to adequate network coverage for dermatologic care within Medicare Advantage plans and advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans. H.R.8163 - Provider Reimbursement Stability Act of 2026.

Adequacy of Medicare physician payments for physicians and implementation of the Medicare Access and CHIP Reauthorization Act, including related provisions in H.R. 879 Medicare Patient and Practice Stabilization Act of 2025, S. 891 the Bipartisan Health Care Act of 2025 and H.R. 1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21, and related to physician payment adjustment of 2.5%. Issues related to adequate network coverage for ophthalmology care within Medicare Advantage plans and advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans, Medicare reimbursement for telemedicine, and extending Medicare Telehealth Flexibilities. Use of step therapy in Medicare and health insurance coverage. Enhance Center for Medicare & Medicaid Innovation quality initiatives and patient access to Medicare Part B covered drugs, including monitor CMMI Medicare Part B drug-related demonstrations. H.R.8163 - Provider Reimbursement Stability Act of 2026.

Adequacy of Medicare physician payments for physicians and implementation of the Medicare Access and CHIP Reauthorization Act, including related provisions in H.R. 879 Medicare Patient and Practice Stabilization Act of 2025, S. 891 the Bipartisan Health Care Act of 2025 and H.R. 1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21, and related to physician payment adjustment of 2.5%. Issues related to adequate network coverage for ophthalmology care within Medicare Advantage plans and advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans, Medicare reimbursement for telemedicine, and extending Medicare Telehealth Flexibilities. Use of step therapy in Medicare and health insurance coverage. Enhance Center for Medicare & Medicaid Innovation quality initiatives and patient access to Medicare Part B covered drugs, including monitor CMMI Medicare Part B drug-related demonstrations. H.R.8163 - Provider Reimbursement Stability Act of 2026. Issues related to modifier 25 in the 2027 physician fee schedule.

Adequacy of Medicare physician payments for physicians and implementation of the Medicare Access and CHIP Reauthorization Act, including related provisions in H.R. 879 Medicare Patient and Practice Stabilization Act of 2025, S. 891 the Bipartisan Health Care Act of 2025 and H.R. 1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21, and related to physician payment adjustment of 2.5%. Issues related to adequate network coverage for ophthalmology care within Medicare Advantage plans and advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans, Medicare reimbursement for telemedicine, and extending Medicare Telehealth Flexibilities. Use of step therapy in Medicare and health insurance coverage. Enhance Center for Medicare & Medicaid Innovation quality initiatives and patient access to Medicare Part B covered drugs, including monitor CMMI Medicare Part B drug-related demonstrations. H.R.8163 - Provider Reimbursement Stability Act of 2026.

Adequacy of Medicare physician payments for physicians and implementation of the Medicare Access and CHIP Reauthorization Act, including related provisions in H.R. 879 Medicare Patient and Practice Stabilization Act of 2025, S. 891 the Bipartisan Health Care Act of 2025 and H.R. 1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21, and related to physician payment adjustment of 2.5%. Issues related to adequate network coverage for ophthalmology care within Medicare Advantage plans and advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans, Medicare reimbursement for telemedicine, and extending Medicare Telehealth Flexibilities. Use of step therapy in Medicare and health insurance coverage. Enhance Center for Medicare & Medicaid Innovation quality initiatives and patient access to Medicare Part B covered drugs, including monitor CMMI Medicare Part B drug-related demonstrations. H.R.8163 - Provider Reimbursement Stability Act of 2026.

Update and reforms to Medicare payments for physicians and implementation of related provisions of the Medicare Access and CHIP Reauthorization Act (MACRA), including regulatory relief for physicians in the MACRA Quality Payment Program, evaluation and management (E/M) codes and related legislative issues related to payment for E/M codes, and qualified clinical data registries, including related provisions in H.R. 879 - Medicare Patient and Practice Stabilization Act of 2025, S. 891 - Bipartisan Health Care Act, and H.R. 1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21. Issues related to adequate network coverage for dermatologic care within Medicare Advantage plans and advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans. H.R.8163 - Provider Reimbursement Stability Act of 2026.

Update and reforms to Medicare payments for physicians and implementation of related provisions of the Medicare Access and CHIP Reauthorization Act (MACRA), including regulatory relief for physicians in the MACRA Quality Payment Program, evaluation and management (E/M) codes and related legislative issues related to payment for E/M codes, and qualified clinical data registries, including related provisions in H.R. 879 - Medicare Patient and Practice Stabilization Act of 2025, S. 891 - Bipartisan Health Care Act, and H.R. 1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21. Issues related to adequate network coverage for dermatologic care within Medicare Advantage plans and advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans. H.R.8163 - Provider Reimbursement Stability Act of 2026.

Adequacy of Medicare physician payments for physicians and implementation of the Medicare Access and CHIP Reauthorization Act, including related provisions in H.R. 879 Medicare Patient and Practice Stabilization Act of 2025, S. 891 the Bipartisan Health Care Act of 2025 and H.R. 1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21, and related to physician payment adjustment of 2.5%. Issues related to adequate network coverage for ophthalmology care within Medicare Advantage plans and advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans, Medicare reimbursement for telemedicine, and extending Medicare Telehealth Flexibilities. Use of step therapy in Medicare and health insurance coverage. Enhance Center for Medicare & Medicaid Innovation quality initiatives and patient access to Medicare Part B covered drugs, including monitor CMMI Medicare Part B drug-related demonstrations. H.R.8163 - Provider Reimbursement Stability Act of 2026.

Adequacy of Medicare physician payments for physicians and implementation of the Medicare Access and CHIP Reauthorization Act, including related provisions in H.R. 879 Medicare Patient and Practice Stabilization Act of 2025, S. 891 the Bipartisan Health Care Act of 2025 and H.R. 1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21, and related to physician payment adjustment of 2.5%. Issues related to adequate network coverage for ophthalmology care within Medicare Advantage plans and advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans, Medicare reimbursement for telemedicine, and extending Medicare Telehealth Flexibilities. Use of step therapy in Medicare and health insurance coverage. Enhance Center for Medicare & Medicaid Innovation quality initiatives and patient access to Medicare Part B covered drugs, including monitor CMMI Medicare Part B drug-related demonstrations. H.R.8163 - Provider Reimbursement Stability Act of 2026. Issues related to modifier 25 in the 2027 physician fee schedule.

Legislative and regulatory issues related to emergency medicine, including provisions found in H.R. 1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21. Additionally, issues such as surprise medical billing; mental health including H.R.929 / S.266, Dr. Lorna Breen Health Care Provider Protection Reauthorization Act; Medicare payment including, H.R. 879 Medicare Patient and Practice Stabilization Act of 2025; workforce issues, drug shortages and rural emergency hospitals. Support of S. 891 the Bipartisan Health Care Act, S.1974 the Addressing Boarding and Crowding in the Emergency Department (ABC-ED) Act of 2025.

Update and reforms to Medicare payments for physicians and implementation of related provisions of the Medicare Access and CHIP Reauthorization Act (MACRA), including regulatory relief for physicians in the MACRA Quality Payment Program, evaluation and management (E/M) codes and related legislative issues related to payment for E/M codes, and qualified clinical data registries, including related provisions in H.R. 879 - Medicare Patient and Practice Stabilization Act of 2025, S. 891 - Bipartisan Health Care Act, and H.R. 1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21. Issues related to adequate network coverage for dermatologic care within Medicare Advantage plans and advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans. H.R.8163 - Provider Reimbursement Stability Act of 2026. Issues related to modifier 25 in the 2027 physician fee schedule.

Legislative and regulatory issues related to emergency medicine, including provisions found in H.R. 1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21. Additionally, issues such as surprise medical billing; mental health including H.R.929 / S.266, Dr. Lorna Breen Health Care Provider Protection Reauthorization Act; Medicare payment including, H.R. 879 Medicare Patient and Practice Stabilization Act of 2025; workforce issues, drug shortages and rural emergency hospitals. Support of S. 891 the Bipartisan Health Care Act, S.1974 the Addressing Boarding and Crowding in the Emergency Department (ABC-ED) Act of 2025.

Legislative and regulatory issues related to emergency medicine, including provisions found in H.R. 1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21. Additionally, issues such as surprise medical billing; mental health including H.R.929 / S.266, Dr. Lorna Breen Health Care Provider Protection Reauthorization Act; Medicare payment including, H.R. 879 Medicare Patient and Practice Stabilization Act of 2025; workforce issues, drug shortages and rural emergency hospitals. Support of S. 891 the Bipartisan Health Care Act, S.1974 the Addressing Boarding and Crowding in the Emergency Department (ABC-ED) Act of 2025.

Legislative and regulatory issues related to emergency medicine, including issues such as surprise medical billing, Medicare payment reform, workforce issues, drug shortages and rural emergency hospitals. Support of S. 891 the Bipartisan Health Care Act, S.1974 the Addressing Boarding and Crowding in the Emergency Department (ABC-ED) Act of 2025.

Legislative and regulatory issues related to emergency medicine, including issues such as surprise medical billing, Medicare payment reform, workforce issues, drug shortages and rural emergency hospitals. Support of S. 891 the Bipartisan Health Care Act, S.1974 the Addressing Boarding and Crowding in the Emergency Department (ABC-ED) Act of 2025.

Issues related to Tribal Health, Appropriations, and Health Care. H.R. 3620/S. 2098 - Southcentral Foundation Land Transfer Act of 2025.

Legislative and regulatory issues related to emergency medicine, including provisions found in H.R. 1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21. Additionally, issues such as surprise medical billing; mental health including H.R.929 / S.266, Dr. Lorna Breen Health Care Provider Protection Reauthorization Act; Medicare payment including, H.R. 879 Medicare Patient and Practice Stabilization Act of 2025; workforce issues, drug shortages and rural emergency hospitals. Support of S. 891 the Bipartisan Health Care Act, S.1974 the Addressing Boarding and Crowding in the Emergency Department (ABC-ED) Act of 2025.

Adequacy of Medicare physician payments for physicians and implementation of the Medicare Access and CHIP Reauthorization Act, including related provisions in H.R. 879 Medicare Patient and Practice Stabilization Act of 2025, S. 891 the Bipartisan Health Care Act of 2025 and H.R. 1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21, and related to physician payment adjustment of 2.5%. Issues related to adequate network coverage for ophthalmology care within Medicare Advantage plans and advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans, Medicare reimbursement for telemedicine, and extending Medicare Telehealth Flexibilities. Use of step therapy in Medicare and health insurance coverage. Enhance Center for Medicare & Medicaid Innovation quality initiatives and patient access to Medicare Part B covered drugs, including monitor CMMI Medicare Part B drug-related demonstrations. H.R.8163 - Provider Reimbursement Stability Act of 2026.

Update and reforms to Medicare payments for physicians and implementation of related provisions of the Medicare Access and CHIP Reauthorization Act (MACRA), including regulatory relief for physicians in the MACRA Quality Payment Program, evaluation and management (E/M) codes and related legislative issues related to payment for E/M codes, and qualified clinical data registries, including related provisions in H.R. 879 - Medicare Patient and Practice Stabilization Act of 2025, S. 891 - Bipartisan Health Care Act, and H.R. 1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21. Issues related to adequate network coverage for dermatologic care within Medicare Advantage plans and advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans. H.R.8163 - Provider Reimbursement Stability Act of 2026. Issues related to modifier 25 in the 2027 physician fee schedule.

Adequacy of Medicare physician payments for physicians and implementation of the Medicare Access and CHIP Reauthorization Act, including related provisions in H.R. 879 Medicare Patient and Practice Stabilization Act of 2025, S. 891 the Bipartisan Health Care Act of 2025 and H.R. 1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21, and related to physician payment adjustment of 2.5%. Issues related to adequate network coverage for ophthalmology care within Medicare Advantage plans and advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans, Medicare reimbursement for telemedicine, and extending Medicare Telehealth Flexibilities. Use of step therapy in Medicare and health insurance coverage. Enhance Center for Medicare & Medicaid Innovation quality initiatives and patient access to Medicare Part B covered drugs, including monitor CMMI Medicare Part B drug-related demonstrations. H.R.8163 - Provider Reimbursement Stability Act of 2026. Issues related to modifier 25 in the 2027 physician fee schedule.

Update and reforms to Medicare payments for physicians and implementation of related provisions of the Medicare Access and CHIP Reauthorization Act (MACRA), including regulatory relief for physicians in the MACRA Quality Payment Program, evaluation and management (E/M) codes and related legislative issues related to payment for E/M codes, and qualified clinical data registries, including related provisions in H.R. 879 - Medicare Patient and Practice Stabilization Act of 2025, S. 891 - Bipartisan Health Care Act, and H.R. 1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21. Issues related to adequate network coverage for dermatologic care within Medicare Advantage plans and advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans. H.R.8163 - Provider Reimbursement Stability Act of 2026.

Adequacy of Medicare physician payments for physicians and implementation of the Medicare Access and CHIP Reauthorization Act, including related provisions in H.R. 879 Medicare Patient and Practice Stabilization Act of 2025, S. 891 the Bipartisan Health Care Act of 2025 and H.R. 1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21, and related to physician payment adjustment of 2.5%. Issues related to adequate network coverage for ophthalmology care within Medicare Advantage plans and advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans, Medicare reimbursement for telemedicine, and extending Medicare Telehealth Flexibilities. Use of step therapy in Medicare and health insurance coverage. Enhance Center for Medicare & Medicaid Innovation quality initiatives and patient access to Medicare Part B covered drugs, including monitor CMMI Medicare Part B drug-related demonstrations. H.R.8163 - Provider Reimbursement Stability Act of 2026.

Update and reforms to Medicare payments for physicians and implementation of related provisions of the Medicare Access and CHIP Reauthorization Act (MACRA), including regulatory relief for physicians in the MACRA Quality Payment Program, evaluation and management (E/M) codes and related legislative issues related to payment for E/M codes, and qualified clinical data registries, including related provisions in H.R. 879 - Medicare Patient and Practice Stabilization Act of 2025, S. 891 - Bipartisan Health Care Act, and H.R. 1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21. Issues related to adequate network coverage for dermatologic care within Medicare Advantage plans and advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans. H.R.8163 - Provider Reimbursement Stability Act of 2026.

Legislative and regulatory issues related to emergency medicine, including issues such as surprise medical billing, Medicare payment reform, workforce issues, drug shortages and rural emergency hospitals. Support of S. 891 the Bipartisan Health Care Act, S.1974 the Addressing Boarding and Crowding in the Emergency Department (ABC-ED) Act of 2025.

Legislative and regulatory issues related to emergency medicine, including provisions found in H.R. 1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21. Additionally, issues such as surprise medical billing; mental health including H.R.929 / S.266, Dr. Lorna Breen Health Care Provider Protection Reauthorization Act; Medicare payment including, H.R. 879 Medicare Patient and Practice Stabilization Act of 2025; workforce issues, drug shortages and rural emergency hospitals. Support of S. 891 the Bipartisan Health Care Act, S.1974 the Addressing Boarding and Crowding in the Emergency Department (ABC-ED) Act of 2025.

Legislative and regulatory issues related to emergency medicine, including issues such as surprise medical billing, Medicare payment reform, workforce issues, drug shortages and rural emergency hospitals. Support of S. 891 the Bipartisan Health Care Act, S.1974 the Addressing Boarding and Crowding in the Emergency Department (ABC-ED) Act of 2025.

Medicare Part B coverage and reimbursement issues for biotechnology treatments and issues related to the Medicare Part D coverage, including issues found in H.R. 1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21

Issues regarding the Inflation Reduction Act (IRA) P.L. No: 117-169, drug pricing, and efforts to create a Neuroscience Center of Excellence at FDA. PBM Issues, including H.R./S._ Modernizing and Ensuring PBM Accountability Act and H.R./S._Lower Costs, More Transparency Act. Issues regarding effective solutions for improving clinical care in long-term care settings and other solutions aimed at improving the diagnosis and management of neuropsychiatric symptoms (NPS) in dementia. Orphan Drug Provisions included in HR.1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21.

Adequacy of Medicare physician payments for physicians and implementation of the Medicare Access and CHIP Reauthorization Act, including related provisions in H.R. 879 Medicare Patient and Practice Stabilization Act of 2025, S. 891 the Bipartisan Health Care Act of 2025 and H.R. 1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21, and related to physician payment adjustment of 2.5%. Issues related to adequate network coverage for ophthalmology care within Medicare Advantage plans and advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans, Medicare reimbursement for telemedicine, and extending Medicare Telehealth Flexibilities. Use of step therapy in Medicare and health insurance coverage. Enhance Center for Medicare & Medicaid Innovation quality initiatives and patient access to Medicare Part B covered drugs, including monitor CMMI Medicare Part B drug-related demonstrations.

Monitoring legislative and regulatory issues related to pharmacies. Medicaid prescription drug reimbursement. Pharmacy Benefit Manager provisions included in H.R. 1 the One Big Beautiful Bill Act (OBBB) P.L. 119-21.

Legislative issues related to Medicare Part B prescription drug reimbursement. Pharmacy Benefit Management Reform in Medicare Part D, including provisions found in H.R. 1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21.

Legislative and regulatory issues related to emergency medicine, including provisions found in H.R. 1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21. Additionally, issues such as surprise medical billing; mental health including H.R.929 / S.266, Dr. Lorna Breen Health Care Provider Protection Reauthorization Act; Medicare payment including, H.R. 879 Medicare Patient and Practice Stabilization Act of 2025; workforce issues, drug shortages and rural emergency hospitals. Support of S. 891 the Bipartisan Health Care Act, S.1974 the Addressing Boarding and Crowding in the Emergency Department (ABC-ED) Act of 2025.

Medicare Part B coverage and reimbursement issues for biotechnology treatments and issues related to the Medicare Part D coverage, including issues found in H.R. 1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21

Monitoring legislative and regulatory issues related to pharmacies. Medicaid prescription drug reimbursement. Pharmacy Benefit Manager provisions included in H.R. 1 the One Big Beautiful Bill Act (OBBB) P.L. 119-21.

Adequacy of Medicare physician payments for physicians and implementation of the Medicare Access and CHIP Reauthorization Act, including related provisions in H.R. 879 Medicare Patient and Practice Stabilization Act of 2025, S. 891 the Bipartisan Health Care Act of 2025 and H.R. 1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21, and related to physician payment adjustment of 2.5%. Issues related to adequate network coverage for ophthalmology care within Medicare Advantage plans and advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans, Medicare reimbursement for telemedicine, and extending Medicare Telehealth Flexibilities. Use of step therapy in Medicare and health insurance coverage. Enhance Center for Medicare & Medicaid Innovation quality initiatives and patient access to Medicare Part B covered drugs, including monitor CMMI Medicare Part B drug-related demonstrations.

Issues regarding the Inflation Reduction Act (IRA) P.L. No: 117-169, drug pricing, and efforts to create a Neuroscience Center of Excellence at FDA. PBM Issues, including H.R./S._ Modernizing and Ensuring PBM Accountability Act and H.R./S._Lower Costs, More Transparency Act. Issues regarding effective solutions for improving clinical care in long-term care settings and other solutions aimed at improving the diagnosis and management of neuropsychiatric symptoms (NPS) in dementia. Orphan Drug Provisions included in HR.1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21.

Legislative issues related to access to pharmaceuticals; Rebates in Medicaid and for dual-eligibles; Medicaid coverage issues; 340B Drug Program; Medicare Part B and D prescription drug reimbursement. Pharmacy Benefit Management Reform in Medicare Part D, including provisions found in H.R. 1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21.

Update and reforms to Medicare payments for physicians and implementation of related provisions of the Medicare Access and CHIP Reauthorization Act (MACRA), including regulatory relief for physicians in the MACRA Quality Payment Program, evaluation and management (E/M) codes and related legislative issues related to payment for E/M codes, and qualified clinical data registries, including related provisions in H.R. 879 - Medicare Patient and Practice Stabilization Act of 2025, S. 891 - Bipartisan Health Care Act, and H.R. 1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21. Issues related to adequate network coverage for dermatologic care within Medicare Advantage plans and advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans.

Medicare Part B coverage and reimbursement issues for biotechnology treatments and issues related to the Medicare Part D coverage, including issues found in H.R. 1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21

Issues regarding the Inflation Reduction Act (IRA) P.L. No: 117-169, drug pricing, and efforts to create a Neuroscience Center of Excellence at FDA. PBM Issues, including H.R./S._ Modernizing and Ensuring PBM Accountability Act and H.R./S._Lower Costs, More Transparency Act. Issues regarding effective solutions for improving clinical care in long-term care settings and other solutions aimed at improving the diagnosis and management of neuropsychiatric symptoms (NPS) in dementia. Orphan Drug Provisions included in HR.1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21.

Update and reforms to Medicare payments for physicians and implementation of related provisions of the Medicare Access and CHIP Reauthorization Act (MACRA), including regulatory relief for physicians in the MACRA Quality Payment Program, evaluation and management (E/M) codes and related legislative issues related to payment for E/M codes, and qualified clinical data registries, including related provisions in H.R. 879 - Medicare Patient and Practice Stabilization Act of 2025, S. 891 - Bipartisan Health Care Act, and H.R. 1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21. Issues related to adequate network coverage for dermatologic care within Medicare Advantage plans and advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans.

Update and reforms to Medicare payments for physicians and implementation of related provisions of the Medicare Access and CHIP Reauthorization Act (MACRA), including regulatory relief for physicians in the MACRA Quality Payment Program, evaluation and management (E/M) codes and related legislative issues related to payment for E/M codes, and qualified clinical data registries, including related provisions in H.R. 879 - Medicare Patient and Practice Stabilization Act of 2025, S. 891 - Bipartisan Health Care Act, and H.R. 1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21. Issues related to adequate network coverage for dermatologic care within Medicare Advantage plans and advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans.

Monitoring legislative and regulatory issues related to pharmacies. Medicaid prescription drug reimbursement. Pharmacy Benefit Manager provisions included in H.R. 1 the One Big Beautiful Bill Act (OBBB) P.L. 119-21.

Legislative and regulatory issues related to emergency medicine, including provisions found in H.R. 1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21. Additionally, issues such as surprise medical billing; mental health including H.R.929 / S.266, Dr. Lorna Breen Health Care Provider Protection Reauthorization Act; Medicare payment including, H.R. 879 Medicare Patient and Practice Stabilization Act of 2025; workforce issues, drug shortages and rural emergency hospitals. Support of S. 891 the Bipartisan Health Care Act.

Legislative and regulatory issues related to emergency medicine, including provisions found in H.R. 1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21. Additionally, issues such as surprise medical billing; mental health including H.R.929 / S.266, Dr. Lorna Breen Health Care Provider Protection Reauthorization Act; Medicare payment including, H.R. 879 Medicare Patient and Practice Stabilization Act of 2025; workforce issues, drug shortages and rural emergency hospitals. Support of S. 891 the Bipartisan Health Care Act, S.1974 the Addressing Boarding and Crowding in the Emergency Department (ABC-ED) Act of 2025.

Adequacy of Medicare physician payments for physicians and implementation of the Medicare Access and CHIP Reauthorization Act, including related provisions in H.R. 879 Medicare Patient and Practice Stabilization Act of 2025, S. 891 the Bipartisan Health Care Act of 2025 and H.R. 1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21, and related to physician payment adjustment of 2.5%. Issues related to adequate network coverage for ophthalmology care within Medicare Advantage plans and advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans, Medicare reimbursement for telemedicine, and extending Medicare Telehealth Flexibilities. Use of step therapy in Medicare and health insurance coverage. Enhance Center for Medicare & Medicaid Innovation quality initiatives and patient access to Medicare Part B covered drugs, including monitor CMMI Medicare Part B drug-related demonstrations.

Repeal Section 6001 of the Affordable Care Act - section 6001 prohibits expansion of physician-led hospitals - including related provisions in H.R. 2191. Issues regarding CMMI demonstration and Medicare 2-2-2 policy.

Repeal Section 6001 of the Affordable Care Act - section 6001 prohibits expansion of physician-led hospitals - including related provisions in H.R. 2191. Issues regarding CMMI demonstration and Medicare 2-2-2 policy.

Repeal Section 6001 of the Affordable Care Act - section 6001 prohibits expansion of physician-led hospitals - including related provisions in H.R. 2191. Issues regarding CMMI demonstration and Medicare 2-2-2 policy.

Legislative and regulatory issues related to physical therapy. Workforce issues, including H.R. 4878/S. 2459_Enabling More of the Physical and Occupational Workforce to Engage in Rehabilitation Act. Pelvic Health, including H.R. 4074/S._Optimizing Postpartum Outcomes Act and issues related to PT in the military; H.R./S._Remove Duplicative Unnecessary Clerical Exchanges Act or REDUCE Act.

Legislative and regulatory issues related to physical therapy. Workforce issues, including H.R. 4878/S. 2459_Enabling More of the Physical and Occupational Workforce to Engage in Rehabilitation Act. Pelvic Health, including H.R. 4074/S._Optimizing Postpartum Outcomes Act and issues related to PT in the military; H.R./S._Remove Duplicative Unnecessary Clerical Exchanges Act or REDUCE Act.

Advocacy for improving the NIL (name image likeness) program. H.R. 4312 - Student Compensation and Opportunity through Rights and Endorsements (SCORE) Act; S.2932 - Student Athlete Fairness and Enforcement (SAFE) Act.

Legislative and regulatory issues related to physical therapy. Workforce issues, including H.R. 4878/S. 2459_Enabling More of the Physical and Occupational Workforce to Engage in Rehabilitation Act. Pelvic Health, including H.R. 4074/S._Optimizing Postpartum Outcomes Act and issues related to PT in the military; H.R./S._Remove Duplicative Unnecessary Clerical Exchanges Act or REDUCE Act.

Legislative and regulatory issues related to physical therapy. Workforce issues, including H.R. 4878/S. 2459_Enabling More of the Physical and Occupational Workforce to Engage in Rehabilitation Act. Pelvic Health, including H.R. 4074/S._Optimizing Postpartum Outcomes Act and issues related to PT in the military; H.R./S._Remove Duplicative Unnecessary Clerical Exchanges Act or REDUCE Act.

Adequacy of Medicare physician payments for physicians and implementation of the Medicare Access and CHIP Reauthorization Act, including related provisions in H.R. 879 Medicare Patient and Practice Stabilization Act of 2025 and S. 891 the Bipartisan Health Care Act of 2025 and related to physician payment adjustment of 2.5%. Issues related to adequate network coverage for ophthalmology care within Medicare Advantage plans and advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans, Medicare reimbursement for telemedicine, and extending Medicare Telehealth Flexibilities. Use of step therapy in Medicare and health insurance coverage. Enhance Center for Medicare & Medicaid Innovation quality initiatives and patient access to Medicare Part B covered drugs, including monitor CMMI Medicare Part B drug-related demonstrations.

Update and reforms to Medicare payments for physicians and implementation of related provisions of the Medicare Access and CHIP Reauthorization Act (MACRA), including regulatory relief for physicians in the MACRA Quality Payment Program, evaluation and management (E/M) codes and related legislative issues related to payment for E/M codes, and qualified clinical data registries, including related provisions in H.R. 879 - Medicare Patient and Practice Stabilization Act of 2025 and S. 891 - Bipartisan Health Care Act. Issues related to adequate network coverage for dermatologic care within Medicare Advantage plans and advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans.

Adequacy of Medicare physician payments for physicians and implementation of the Medicare Access and CHIP Reauthorization Act, including related provisions in H.R. 879 Medicare Patient and Practice Stabilization Act of 2025, S. 891 the Bipartisan Health Care Act of 2025 and H.R. 1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21, and related to physician payment adjustment of 2.5%. Issues related to adequate network coverage for ophthalmology care within Medicare Advantage plans and advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans, Medicare reimbursement for telemedicine, and extending Medicare Telehealth Flexibilities. Use of step therapy in Medicare and health insurance coverage. Enhance Center for Medicare & Medicaid Innovation quality initiatives and patient access to Medicare Part B covered drugs, including monitor CMMI Medicare Part B drug-related demonstrations.

Adequacy of Medicare physician payments for physicians and implementation of the Medicare Access and CHIP Reauthorization Act, including related provisions in H.R. 879 Medicare Patient and Practice Stabilization Act of 2025, S. 891 the Bipartisan Health Care Act of 2025 and H.R. 1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21, and related to physician payment adjustment of 2.5%. Issues related to adequate network coverage for ophthalmology care within Medicare Advantage plans and advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans, Medicare reimbursement for telemedicine, and extending Medicare Telehealth Flexibilities. Use of step therapy in Medicare and health insurance coverage. Enhance Center for Medicare & Medicaid Innovation quality initiatives and patient access to Medicare Part B covered drugs, including monitor CMMI Medicare Part B drug-related demonstrations.

Legislative and regulatory issues related to emergency medicine, including provisions found in H.R. 1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21. Additionally, issues such as surprise medical billing; mental health including H.R.929 / S.266, Dr. Lorna Breen Health Care Provider Protection Reauthorization Act; Medicare payment including, H.R. 879 Medicare Patient and Practice Stabilization Act of 2025; workforce issues, drug shortages and rural emergency hospitals. Support of S. 891 the Bipartisan Health Care Act, S.1974 the Addressing Boarding and Crowding in the Emergency Department (ABC-ED) Act of 2025.

Legislative and regulatory issues related to emergency medicine, including provisions found in H.R. 1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21. Additionally, issues such as surprise medical billing; mental health including H.R.929 / S.266, Dr. Lorna Breen Health Care Provider Protection Reauthorization Act; Medicare payment including, H.R. 879 Medicare Patient and Practice Stabilization Act of 2025; workforce issues, drug shortages and rural emergency hospitals. Support of S. 891 the Bipartisan Health Care Act, S.1974 the Addressing Boarding and Crowding in the Emergency Department (ABC-ED) Act of 2025.

Update and reforms to Medicare payments for physicians and implementation of related provisions of the Medicare Access and CHIP Reauthorization Act (MACRA), including regulatory relief for physicians in the MACRA Quality Payment Program, evaluation and management (E/M) codes and related legislative issues related to payment for E/M codes, and qualified clinical data registries, including related provisions in H.R. 879 - Medicare Patient and Practice Stabilization Act of 2025, S. 891 - Bipartisan Health Care Act, and H.R. 1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21. Issues related to adequate network coverage for dermatologic care within Medicare Advantage plans and advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans.

Update and reforms to Medicare payments for physicians and implementation of related provisions of the Medicare Access and CHIP Reauthorization Act (MACRA), including regulatory relief for physicians in the MACRA Quality Payment Program, evaluation and management (E/M) codes and related legislative issues related to payment for E/M codes, and qualified clinical data registries, including related provisions in H.R. 879 - Medicare Patient and Practice Stabilization Act of 2025, S. 891 - Bipartisan Health Care Act, and H.R. 1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21. Issues related to adequate network coverage for dermatologic care within Medicare Advantage plans and advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans.

Legislative and regulatory issues related to emergency medicine, including provisions found in H.R. 1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21. Additionally, issues such as surprise medical billing; mental health including H.R.929 / S.266, Dr. Lorna Breen Health Care Provider Protection Reauthorization Act; Medicare payment including, H.R. 879 Medicare Patient and Practice Stabilization Act of 2025; workforce issues, drug shortages and rural emergency hospitals. Support of S. 891 the Bipartisan Health Care Act.

Update and reforms to Medicare payments for physicians and implementation of related provisions of the Medicare Access and CHIP Reauthorization Act (MACRA), including regulatory relief for physicians in the MACRA Quality Payment Program, evaluation and management (E/M) codes and related legislative issues related to payment for E/M codes, and qualified clinical data registries, including related provisions in H.R. 879 - Medicare Patient and Practice Stabilization Act of 2025, S. 891 - Bipartisan Health Care Act, and H.R. 1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21. Issues related to adequate network coverage for dermatologic care within Medicare Advantage plans and advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans.

Legislative and regulatory issues related to emergency medicine, including surprise medical billing; mental health including H.R.929 / S.266, Dr. Lorna Breen Health Care Provider Protection Reauthorization Act; Medicare payment including H.R. 879 Medicare Patient and Practice Stabilization Act of 2025; workforce issues, drug shortages and rural emergency hospitals. Support of S. 891 the Bipartisan Health Care Act.

Adequacy of Medicare physician payments for physicians and implementation of the Medicare Access and CHIP Reauthorization Act, including related provisions in H.R. 879 Medicare Patient and Practice Stabilization Act of 2025, S. 891 the Bipartisan Health Care Act of 2025 and H.R. 1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21, and related to physician payment adjustment of 2.5%. Issues related to adequate network coverage for ophthalmology care within Medicare Advantage plans and advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans, Medicare reimbursement for telemedicine, and extending Medicare Telehealth Flexibilities. Use of step therapy in Medicare and health insurance coverage. Enhance Center for Medicare & Medicaid Innovation quality initiatives and patient access to Medicare Part B covered drugs, including monitor CMMI Medicare Part B drug-related demonstrations.

Legislative and regulatory issues related to emergency medicine, including surprise medical billing; mental health including H.R.929 / S.266, Dr. Lorna Breen Health Care Provider Protection Reauthorization Act; Medicare payment including H.R. 879 Medicare Patient and Practice Stabilization Act of 2025; workforce issues, drug shortages and rural emergency hospitals. Support of S. 891 the Bipartisan Health Care Act.

Legislative and regulatory issues related to emergency medicine, including provisions found in H.R. 1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21. Additionally, issues such as surprise medical billing; mental health including H.R.929 / S.266, Dr. Lorna Breen Health Care Provider Protection Reauthorization Act; Medicare payment including, H.R. 879 Medicare Patient and Practice Stabilization Act of 2025; workforce issues, drug shortages and rural emergency hospitals. Support of S. 891 the Bipartisan Health Care Act, S.1974 the Addressing Boarding and Crowding in the Emergency Department (ABC-ED) Act of 2025.

Legislative and regulatory issues related to emergency medicine, including provisions found in H.R. 1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21. Additionally, issues such as surprise medical billing; mental health including H.R.929 / S.266, Dr. Lorna Breen Health Care Provider Protection Reauthorization Act; Medicare payment including, H.R. 879 Medicare Patient and Practice Stabilization Act of 2025; workforce issues, drug shortages and rural emergency hospitals. Support of S. 891 the Bipartisan Health Care Act.

Legislative and regulatory issues related to emergency medicine, including provisions found in H.R. 1, the One Big Beautiful Bill Act (OBBB) P.L. 119-21. Additionally, issues such as surprise medical billing; mental health including H.R.929 / S.266, Dr. Lorna Breen Health Care Provider Protection Reauthorization Act; Medicare payment including, H.R. 879 Medicare Patient and Practice Stabilization Act of 2025; workforce issues, drug shortages and rural emergency hospitals. Support of S. 891 the Bipartisan Health Care Act, S.1974 the Addressing Boarding and Crowding in the Emergency Department (ABC-ED) Act of 2025.